We intend to study factors which induce or amplify MHC antigen expression on parenchymal cells of allografts. Pancreatic islet cells should prove interesting for these studies, since passenger leukocytes with antigen presenting function can be deleted from them by tissue culture, and since islet cells ordinarily express only class I antigens, but can be induced by exposure to lymphokines (such as interferon) to express class II antigens and to increase their expression of class I antigens. Assessment of whether modulation of MHC antigens imparts to islets the potential to present alloantigens or nominal antigens may provide insight into intragraft immuno-regulating mechanisms. We will employ in vitro cytotoxicity assays to test the effect of hyperexpression of class I antigens on islet lysis. Islets induced to express class II neo-antigens will be assessed for antigen presenting capability in vitro and in islet transplant experiments. Islets obtained from a new line of transgenic mice in which beta cell class II expression has been induced by recombinant DNA techniques will be of particular interest. Islet transplant studies will attempt to determine whether Ia bearing beta cells can initiate rejection or autoimmunity. If parenchymal cells are themselves found capable of presenting antigen to T lymphocytes, then blocking MHC antigen induction might be a promising mode of therapeutic intervention before or during allograft rejection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK034878-06
Application #
3233144
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1984-12-01
Project End
1991-11-30
Budget Start
1990-12-01
Budget End
1991-11-30
Support Year
6
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Song, Howard K; Noorchashm, Hooman; Lin, Tina H et al. (2003) Specialized CC-chemokine secretion by Th1 cells in destructive autoimmune myocarditis. J Autoimmun 21:295-303
Yang, Z; Rostami, S; Koeberlein, B et al. (1999) Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig. Transplantation 67:1517-23
Yokoi, Y; Noorchashm, H; Rostami, S Y et al. (1999) Origin, kinetics, and function of chimeric B lymphocytes in liver allografts. Transplantation 68:118-23
Uchikoshi, F; Yang, Z D; Rostami, S et al. (1999) Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes 48:652-7
Noorchashm, H; Lieu, Y K; Rostami, S Y et al. (1999) A direct method for the calculation of alloreactive CD4+ T cell precursor frequency. Transplantation 67:1281-4
Song, H K; Noorchashm, H; Lieu, Y K et al. (1999) Cutting edge: alloimmune responses against major and minor histocompatibility antigens: distinct division kinetics and requirement for CD28 costimulation. J Immunol 162:2467-71
Noorchashm, H; Lieu, Y K; Noorchashm, N et al. (1999) I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol 163:743-50
Noorchashm, H; Noorchashm, N; Kern, J et al. (1997) B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 46:941-6
Naji, A (1996) Induction of tolerance by intrathymic inoculation of alloantigen. Curr Opin Immunol 8:704-9
Campos, L; Deli, B C; Kern, J H et al. (1995) Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts. Transplant Proc 27:254-5

Showing the most recent 10 out of 45 publications